Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Type of study
Language
Year range
1.
IBJ-Iranian Biomedical Journal. 2017; 21 (2): 106-113
in English | IMEMR | ID: emr-186947

ABSTRACT

Background: Most cancer studies focus on exploring non-invasive biomarkers for cancer detection. In the present study, we sought to investigate the expression level of microRNA-21 [miR-21], as a potential diagnostic marker, in serum and stool samples from 40 patients with colorectal cancer [CRC] and 40 healthy controls


Methods: Quantitative real-time RT-PCR was applied to determine the relative expression level of miR-21 in serum and stool. At the same time, the sensitivity and specificity of this marker was evaluated by receiver operating characteristic [ROC] curve analysis


Results: miR-21 expression levels of serum and stool were up-regulated 12.1 [P<0.05, 95% CI: 5.774-34.045] and 10.0 [P<0.05, 95% CI: 0.351-16.260] times in CRC patients, respectively, when compared to the control group. The sensitivity and specificity of miR-21 was found to be 86.05% and 72.97%, respectively [an area under the ROC curve [AUC] of 0.783]. The stool miR-21 level in CRC patients was much higher than that in the healthy controls, showing a sensitivity of 86.05% and a specificity of 81.08% [AUC: 0.829]. The expression level of miR-21 in stool was able to significantly distinguish CRC tumor, node, metastasis stages III-IV from stages I-II, with a sensitivity and specificity of 88.1% and 81.6%, respectively [AUC: 0.872]


Conclusion: The results of this study indicated that miR-21 expression levels in serum and stool can be considered as a potential diagnostic biomarker for the diagnosis of CRC patients. However, more studies are required to confirm the validity of miR-21 as a valuable non-invasive diagnostic tool for CRC

2.
IBJ-Iranian Biomedical Journal. 2015; 19 (1): 57-62
in English | IMEMR | ID: emr-170701

ABSTRACT

One of the limitations in the treatment of common diseases such as cancer chemotherapy is development of multidrug resistance [MDR]. Polymorphisms could alter the expression level of MDR1 gene, which plays an important role in MDR. In this research, the frequency of C3435T, C1236T, and G2677T/A polymorphisms of MDR1 gene was investigated in a large group of population from Hamadan city to provide a sample data resource.Peripheral blood [2 ml] was taken, and DNA extraction was carried out. Multiplexed mutagenically separated PCR, which was followed by polyacrylamide gel electrophoresis and silver staining, was applied to detect the mentioned polymorphisms in 935 individuals. Sequencing performed for confirmation of gel electrophoresis resulted in 10 random cases. In total, alleles and genotypes of 933 persons [776 women and 157 men] were determined. The most frequent alleles of the polymorphisms were: 3435T, C1236, and G2677. The most frequent genotypes were: 3435C/T, 1236C/T, and 2677G/A, and their concurrent presence was also found as the most frequent simultaneous genotypes. There was not any meaningful difference among the prevalence of these genotypes in groups of men and women. Our results were close to those of other studies performed in Iran and compared to the other ethnic groups, which showed more similarity to Asian peoples than Europeans. As an aspect of personalized medicine, it could be used by chemotherapists to improve the routine methods of cancer treatment.

3.
IBJ-Iranian Biomedical Journal. 2015; 19 (4): 188-193
in English | IMEMR | ID: emr-171807

ABSTRACT

Early detection is a key to survival for gastric cancer. Molecular markers such as miRNA [microRNA] can have great importance in the early diagnosis of gastric cancer. Expression of miR-21 and miR-221 are deregulated in many types of human cancers. This study aimed to investigate the differences in miRNA expression patterns within the Iranian population. Total RNA was extracted from gastric cancer tissues and adjacent non-cancerous tissues from 32 patients. Expression levels of miR-21 and miR-221 were detected by Real time RT-PCR using a specific primer, with 5s rRNA as the internal reference gene. Our data showed that the expression levels of miR-21 and miR-221 in gastric cancer samples were significantly higher than in paired non-cancerous samples [P < 0.05]. The receiver operating characteristic [ROC] analyses yielded the area under the curve [AUC] values of 80.30 for miR-21 and 93.30 for miR-221, and combined ROC analysis revealed the highest AUC value of 96.90 in discriminating GC patients from healthy controls. It seems that miR-21 and miR-221 expression pattern in Iranian patients with gastric cancer are similar to any other population. Considering the increased expression level of two miRNAs in cancerous tissue compared to normal tissue as well as the area under ROC curve, miR-21 and miR-221 can be used for early detection of gastric cancer


Subject(s)
Female , Humans , Male , Middle Aged , MicroRNAs , Gene Expression , Biomarkers, Tumor
4.
IBJ-Iranian Biomedical Journal. 2014; 18 (2): 60-66
in English | IMEMR | ID: emr-138732

ABSTRACT

In fertile women, glycodelin and glutathione peroxidase 3 [GPx3] genes expression rises during the luteal phase, with a peak occurring during the implantation window. The expression of these genes decreases in women with myomas. To determine whether myomectomy would reverse glycodelin and GPx3 expression, we evaluated the transcript levels of these genes in the endometrium of patients before and after myomectomy. Expression of glycodelin and GPx3 genes were examined prospectively during the midluteal phase in the endometrium obtained from infertile women with myoma [n = 12] before and three months after myomectomy. Endometrial expression of these genes was evaluated using quantitative real-time RT-PCR. Endometrial glycodelin mRNA expression levels [normalized to 18S rRNA expression] were increased significantly in endometrium of patients after myomectomy [P = 0.02]. GPx3 mRNA expression was increased insignificantly after myomectomy [P = 0.43]. The results showed that myomectomy increased endometrial glycodelin [significantly] and GPx3 [not significantly] gene expression after 3 months. Study at different times and detecting expression of these genes can reveal more details

5.
IBJ-Iranian Biomedical Journal. 2013; 17 (1): 15-21
in English | IMEMR | ID: emr-193079

ABSTRACT

Background: efficient screening for detection of colorectal cancer [CRC] at earlier stages reduces its mortality. The purpose of this study was to investigate expression of carcinoembryonic antigen [CEA] and human telomerase reverse transcriptase [hTERT] mRNA in peripheral blood of CRC patients and to present strategies for early detection screen test


Methods: twenty seven patients in non-metastatic stage and 27 healthy individuals were studied. Expression of CEA, hTERT mRNA and 18srRNA [18s subunit of ribosomal RNA, as reference gene] were determined based on real-time RT-PCR on 3 [micro]g of total RNA from blood in 3 separate vials [1 [micro]g per vial]


Results: positive expression rate of CEA mRNA [78%] and hTERT mRNA [81%] were higher in patient group [P<0.001]. These rates were meaningfully higher than the results of individual vials containing only 1 [micro]g of total RNA. Difference between Ct values of markers with 18srRNA [[DELTA]Ct] was higher in healthy group than patient one. Therefore, a [DELTA]Ct cut-off value was determined for distinguishing between true- and false-positive results. Concurrent expression of both markers was found in 67% of the patients, which was higher than healthy cases [11%]. Combination of concurrent marker expression with cut-off point strategy increased specificity to 100%


Conclusion: these results showed that concurrent evaluation of marker expression and performing the test on 3 [micro]g of samples in 3 separate vials may increase specificity and sensitivity of real-time RT-PCR for early detection of non-metastatic CRC. However, more investigations with larger numbers of samples are needed to verify these results. Iran. Biomed. J. 17 [1]: 15-21, 2013

6.
IJRM-Iranian Journal of Reproductive Medicine. 2013; 11 (12): 983-988
in English | IMEMR | ID: emr-148477

ABSTRACT

HOXA11 and HOXA10 are expressed in endometrium throughout the menstrual cycle and show a dramatic increase during the mid-luteal phase at the time of implantation. The expression of these genes is decreased in women with myomas. To determine whether myomectomy would reverse HOXA11 and HOXA10 expression, we evaluated the transcript levels of these genes in the endometria of patients before and after myomectomy. Expression of HOXA11 and HOXA10 were examined prospectively during the midluteal phase in endometrium obtained from infertile women [n=12] with myoma before and three months after myomectomy. Endometrial HOXA11 and HOXA10 expression were evaluated using quantitative real-time reverse transcriptase-polymerase chain reaction [RT-PCR]. Endometrial HOXA11 and HOXA10 mRNAs expression levels [normalized to 18SrRNA] were increased insignificantly in endometrium of patients after myomectomy [p=0.7 and p=0.15 respectively]. The results suggest that the alteration in expression pattern of these genes could not account for some aspects of fertility after myomectomy


Subject(s)
Humans , Female , Uterine Neoplasms , Endometrial Neoplasms , Leiomyoma/genetics , Genes, Homeobox , Homeodomain Proteins , Embryo Implantation , Endometrium
SELECTION OF CITATIONS
SEARCH DETAIL